Hazel Aranha, Consultant, Gaea Resources (Northport, NY)
Jared Auclair, Director, ICH Q1 Stability Training Center, Biopharmaceutical Analysis & Training Lab (BATL) and Adjunct Professor, Northeastern University and NIBRT (Worcester, MA)
Keith M. Bower, President, CMC Statistics LLC (Seattle, WA)
R. Lee Buckler, President & CEO, RepliCel Life Sciences Inc. (Vancouver, BC, Canada)
Peter Calcott, President and CEO, Calcott Consulting (Berkeley, CA)
Bob Castellucci, Founder and President, Partnership To Prosperity (Philadelphia, PA)
Jason Condon, Director, Drug-Substance Technical Operations, Cue Biopharma (Victor, NY)
John Clark Davies, Senior Software Quality Engineer, Abbott Laboratories (Pickerington, OH)
Jim Faulkner, Venture Partner and Chief Technology Officer, Apple Tree Partners and Ascidian Therapeutics (London, UK)
Hiten Gutka, Senior Scientist, Drug-Product Development, Bristol-Meyers Squibb (Plainsboro, NJ)
Margit Holzer, Scientific Director, Ulysse Consult (Luxembourg)
Susan Dana Jones, Chief of Technical Operations, Tourmaline Bio (Boston, MA)
Alois Jungbauer, Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences (Vienna, Austria)
Blanca Lain, Senior Director and Head of Process Development,